McKinney, Texas-based StatLab Medical Products announced that it has acquired Poly Scientific R&D.
Poly Scientific is one of the leading manufacturers of chemicals, stains and reagents for histology, cytology and microbiology, as well as other items for in-vitro diagnostic testing. The company was founded in 1969 and is based in Bay Shore, New York.
StatLab Medical Products, an Audax Private Equity and Linden Capital Partners portfolio company, is a McKinney, Texas-based developer and manufacturer of histology, cytology and immunohistochemistry diagnostic products. The company partners with anatomic pathology laboratories to provide easy access to more than 3,500 diagnostic products and equipment.
This acquisition expands StatLab’s core manufacturing capabilities to include tissue controls, further advancing its position as a differentiated manufacturer of anatomic pathology consumables, while broadening its market presence. The financial terms of the deal were not disclosed.
According to data captured in the LevinPro HC database, this transaction represents the 33rd Laboratories, MRI and Dialysis acquisition of 2024, and the 17th in the diagnostic specialty. Throughout 2023, 63 diagnostic transactions were announced.
